Avalo Therapeutics (AVTX) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free AVTX Stock Alerts $10.60 -0.22 (-2.03%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Avalo Therapeutics Short Interest DataCurrent Short Volume104,300 sharesPrevious Short Volume153,400 sharesChange Vs. Previous Month-32.01%Dollar Volume Sold Short$1.79 millionShort Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Outstanding Shares1,030,000 sharesPercentage of Shares Shorted10.13%Today's Trading Volume53,056 sharesAverage Trading Volume476,255 sharesToday's Volume Vs. Average11% Short Selling Avalo Therapeutics ? Sign up to receive the latest short interest report for Avalo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAVTX Short Interest Over TimeAVTX Days to Cover Over TimeAVTX Percentage of Float Shorted Over Time Ad Porter & CompanyTruth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. Avalo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024104,300 shares $1.79 million -32.0%N/A0.2 $17.12 4/15/2024153,400 shares $2.34 million +95.4%N/A0.2 $15.24 3/31/202478,500 shares $1.71 million +16.8%N/A0.1 $21.75 3/15/202467,200 shares $293,664.00 +10.3%N/A1.3 $4.37 2/29/202460,900 shares $268,569.00 -4.8%N/A0.7 $4.41 2/15/202464,000 shares $304,640.00 -21.3%N/A0.7 $4.76 Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202481,300 shares $378,045.00 -4.0%N/A0.8 $4.65 1/15/202484,700 shares $484,484.00 +32.1%N/A0.7 $5.72 12/31/202364,100 shares $583,310.00 -99.5%N/A0.4 $9.10 12/15/202312,640,000 shares $758,400.00 +23.8%N/A0.2 $0.06 11/30/202310,210,000 shares $713,679.00 -43.7%N/A0.1 $0.07 11/15/202318,140,000 shares $1.79 million +40.8%N/A0.2 $0.10 10/31/202312,880,000 shares $1.41 million +3.5%N/A0.2 $0.11 10/15/202312,450,000 shares $1.85 million -29.1%N/A0.2 $0.15 9/30/202317,550,000 shares $2.12 million +471.7%90.2%0.3 $0.12 9/15/20233,070,000 shares $406,775.00 +220.1%15.8%0.1 $0.13 8/31/2023959,000 shares $95,900.00 +0.2%5.2%0.1 $0.10 8/15/2023957,300 shares $134,022.00 -10.5%5.2%0.2 $0.14 7/31/20231,070,000 shares $214,000.00 +20.6%5.8%0.6 $0.20 7/15/2023887,000 shares $294,572.70 +41.2%7.4%0.7 $0.33 6/30/2023628,400 shares $223,207.68 +1,528.0%5.3%0.6 $0.36 6/15/202338,600 shares $145,329.00 -9.4%0.4%0.1 $3.77 5/31/202342,600 shares $122,262.00 -2.7%0.4%0.6 $2.87 5/15/202343,800 shares $120,450.00 +17.1%0.4%0.9 $2.75 4/30/202337,400 shares $108,834.00 -23.8%0.3%1.2 $2.91 4/15/202349,100 shares $127,660.00 +172.8%0.4%1.7 $2.60 3/31/202318,000 shares $31,500.00 -3.7%0.2%0.7 $1.75 3/15/202318,700 shares $46,843.50 -24.6%0.2%1.1 $2.51 2/28/202324,800 shares $62,496.00 +30.5%0.4%1.6 $2.52 2/15/202319,000 shares $56,240.00 -32.4%0.3%1.3 $2.96 1/31/202328,100 shares $110,714.00 -30.8%0.3%1.7 $3.94 1/15/202340,600 shares $197,316.00 +17.0%0.5%2.7 $4.86 12/30/202234,700 shares $174,891.47 -15.0%0.4%2.4 $5.04 12/15/202240,800 shares $237,864.00 +9.4%0.5%3 $5.83 11/30/202237,300 shares $204,031.00 +9.1%0.4%2.3 $5.47 11/15/202234,200 shares $198,360.00 -3.1%0.4%1.7 $5.80 10/31/202235,300 shares $211,800.00 -27.5%0.4%1.1 $6.00 10/15/202248,700 shares $258,110.00 +10.9%0.6%1.4 $5.30 9/30/202243,900 shares $145,748.00 -34.1%0.5%1.2 $3.32 9/15/202266,600 shares $279,054.00 +26.1%0.8%1.3 $4.19The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 AVTX Short Interest - Frequently Asked Questions What is Avalo Therapeutics' current short interest? Short interest is the volume of Avalo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 104,300 shares of AVTX short. Learn More on Avalo Therapeutics' current short interest. Which institutional investors are shorting Avalo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avalo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Avalo Therapeutics' short interest increasing or decreasing? Avalo Therapeutics saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 104,300 shares, a drop of 32.0% from the previous total of 153,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avalo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Avalo Therapeutics: RedHill Biopharma Ltd. (2.38%), Pieris Pharmaceuticals, Inc. (1.12%), Monopar Therapeutics Inc. (1.24%), Kiora Pharmaceuticals, Inc. (0.56%), Purple Biotech Ltd (1.18%), FSD Pharma Inc. (1.00%), Edesa Biotech, Inc. (0.69%), Imunon, Inc. (3.95%), Elevai Labs, Inc. (0.48%), Akari Therapeutics, Plc (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Avalo Therapeutics stock? Short selling AVTX is an investing strategy that aims to generate trading profit from Avalo Therapeutics as its price is falling. AVTX shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avalo Therapeutics? A short squeeze for Avalo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTX, which in turn drives the price of the stock up even further. How often is Avalo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MIRA Pharmaceuticals Short Squeeze Moleculin Biotech Short Squeeze Elevai Labs Short Squeeze Guardion Health Sciences Short Squeeze ABVC BioPharma Short Squeeze Monopar Therapeutics Short Squeeze Akari Therapeutics Short Squeeze Aeterna Zentaris Short Squeeze Addex Therapeutics Short Squeeze NuCana Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVTX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper